161 related articles for article (PubMed ID: 26743722)
1. Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression.
Brieler JA; Lustman PJ; Scherrer JF; Salas J; Schneider FD
Fam Pract; 2016 Feb; 33(1):30-6. PubMed ID: 26743722
[TBL] [Abstract][Full Text] [Related]
2. Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes.
van Bastelaar KM; Pouwer F; Geelhoed-Duijvestijn PH; Tack CJ; Bazelmans E; Beekman AT; Heine RJ; Snoek FJ
Diabet Med; 2010 Jul; 27(7):798-803. PubMed ID: 20636961
[TBL] [Abstract][Full Text] [Related]
3. The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA
Rohde C; Knudsen JS; Schmitz N; Østergaard SD; Thomsen RW
Diabetologia; 2021 Feb; 64(2):361-374. PubMed ID: 33073329
[TBL] [Abstract][Full Text] [Related]
4. Achievement of glycemic control and antidepressant medication use in comorbid depression and type II diabetes.
Brieler J; Salas J; Scherrer J
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 35947421
[TBL] [Abstract][Full Text] [Related]
5. Relationship between number of contacts between previous dropouts with type 2 diabetes and health care professionals on glycaemic control: A cohort study in public primary health care.
Kauppila T; Eriksson JG; Honkasalo M; Raina M; Laine MK
Prim Care Diabetes; 2019 Oct; 13(5):468-473. PubMed ID: 30928432
[TBL] [Abstract][Full Text] [Related]
6. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
7. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
[TBL] [Abstract][Full Text] [Related]
8. Frequency of depression in type 2 diabetes mellitus and an analysis of predictive factors.
Arshad AR; Alvi KY
J Pak Med Assoc; 2016 Apr; 66(4):425-9. PubMed ID: 27122269
[TBL] [Abstract][Full Text] [Related]
9. Long-term Association of Depression Symptoms and Antidepressant Medication Use With Incident Cardiovascular Events in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Type 2 Diabetes.
Hazuda HP; Gaussoin SA; Wing RR; Yanovski SZ; Johnson KC; Coday M; Wadden TA; Horton ES; Van Dorsten B; Knowler WC;
Diabetes Care; 2019 May; 42(5):910-918. PubMed ID: 30833373
[TBL] [Abstract][Full Text] [Related]
10. Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study.
Svensson E; Baggesen LM; Thomsen RW; Lyngaa T; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
Diabet Med; 2016 Nov; 33(11):1516-1523. PubMed ID: 27412570
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant medication use for primary care patients with and without medical comorbidities: a national electronic health record (EHR) network study.
Gill JM; Klinkman MS; Chen YX
J Am Board Fam Med; 2010; 23(4):499-508. PubMed ID: 20616292
[TBL] [Abstract][Full Text] [Related]
12. Extent and Predictors of Poor Glycaemic Control among Elderly Pakistani Patients with Type 2 Diabetes Mellitus: A Multi-Centre Cross-Sectional Study.
Atif M; Saleem Q; Asghar S; Malik I; Ahmad N
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658518
[No Abstract] [Full Text] [Related]
13. Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.
Marrero DG; Ma Y; de Groot M; Horton ES; Price DW; Barrett-Connor E; Carnethon MR; Knowler WC;
Psychosom Med; 2015 Apr; 77(3):303-10. PubMed ID: 25775165
[TBL] [Abstract][Full Text] [Related]
14. Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program.
de Groot M; Marrero D; Mele L; Doyle T; Schwartz F; Mather KJ; Goldberg R; Price DW; Ma Y; Knowler WC;
Psychosom Med; 2018; 80(2):167-173. PubMed ID: 29016549
[TBL] [Abstract][Full Text] [Related]
15. A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes.
Hertroijs DFL; Elissen AMJ; Brouwers MCGJ; Schaper NC; Köhler S; Popa MC; Asteriadis S; Hendriks SH; Bilo HJ; Ruwaard D
Diabetes Obes Metab; 2018 Mar; 20(3):681-688. PubMed ID: 29095564
[TBL] [Abstract][Full Text] [Related]
16. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
[TBL] [Abstract][Full Text] [Related]
17. Glycaemic control in native Kuwaiti Arab patients with type 2 diabetes.
Channanath AM; AlWotayan R; Alkandari H; Davidsson L; Tuomilehto J; Thanaraj TA
Prim Care Diabetes; 2018 Dec; 12(6):526-532. PubMed ID: 30115526
[TBL] [Abstract][Full Text] [Related]
18. Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus.
Chang YL; Sheu WH; Lin SY; Liou WS
Clin Exp Med; 2018 Aug; 18(3):383-390. PubMed ID: 29572669
[TBL] [Abstract][Full Text] [Related]
19. Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.
Rosenstock J; Rood J; Cobitz A; Huang C; Garber A
Diabetes Obes Metab; 2006 Nov; 8(6):643-9. PubMed ID: 17026488
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal follow-up study of a type 2 diabetes "lost to follow-up" cohort - positive effect on glycaemic control after changes in medication.
Kauppila T; Laine MK; Honkasalo M; Raina M; Eriksson JG
Int J Circumpolar Health; 2020 Jan; 79(1):1773127. PubMed ID: 32498629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
